Advertisement
Screener

ORCHARD THERAPEUTICS PLC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

ORCHARD THERAPEUTICS PLC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

ORCHARD THERAPEUTICS PLC reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $1.40 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-27.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2020-02-27

  • ORCHARD THERAPEUTICS PLC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2017 was $1.40M.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month
2017-12-31$1.40M
10-K · filed 2020-02-27
2016-12-31$451.00K
20-F · filed 2019-03-22